Analysed INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) News Sources
Intellia Therapeutics (NTLA) Stock Gets FDA Priority Review For Lonvo Z Gene Editing Therapy
22-09-2026
yahoo.com
CRSP, NTLA, BEAM, PRME, EDIT Shares Slip — Did Claude Just Spook Gene-Editing Stocks?
23-09-2026
stocktwits.com
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
06-10-2026
stocktwits.com
Intellia Therapeutics Appoints Jing L. Marantz, M.D., Ph.D., as Chief Medical Officer
13-10-2026
yahoo.com
Intellia Therapeutics (NTLA) Stock Looks Overvalued As Launch Preparations Advance
18-10-2026
yahoo.com
What is the current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The current price of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is $11.23.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is $0.02.
INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) since the previous trading day is 0.1784%.
What is the most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent average sentiment score for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)?
The most recent sentiment for INTELLIA THERAPEUTICS INC (NTLA:NASDAQ) is .
SEC-8K** Filing Available For INTELLIA THERAPEUTICS INC (NTLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.